Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Two Novel Distinct Subtypes of Myeloid Neoplasms Molecularly Associated with Histone H3K36 Methylations

Blood (2015) 126 (23): 2841.

https://doi.org/10.1182/blood.V126.23.2841.2841

Published: 2015

Journal Articles

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 5205.

https://doi.org/10.1182/blood.V126.23.5205.5205

Published: 2015

Journal Articles

Mutational Complexity Is Related To Disease Severity In Systemic Mastocytosis

Blood (2013) 122 (21): 4094.

https://doi.org/10.1182/blood.V122.21.4094.4094

Published: 2013

Journal Articles

Analysis of 12 Genes in 268 Cases with CMML Identifies ASXL1 Mutations As the Most Important Genetic Alteration Associated with Adverse Outcome

Susanne Schnittger, PhD, Manja Meggendorfer, PhD, Vera Grossmann, MSc, Tamara Alpermann, Christiane Eder, PhD, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 3491.

https://doi.org/10.1182/blood.V120.21.3491.3491

Published: 2012

Journal Articles

Acute Lymphoblastic Leukemia (ALL) with Low-Hypodiploid/near Triploid Karyotype Is a Specific Clinical Entity with Poor Outcome

Claudia Haferlach, MD, Melanie Zenger, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 1429.

https://doi.org/10.1182/blood.V120.21.1429.1429

Published: 2012

Journal Articles

Acquisition of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients During the Course of Disease Is Associated with an Unmutated IGHV Status and Mutations in XPO1 and SF3B1

Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Sandra Weissmann, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Lucia Boeck, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 1768.

https://doi.org/10.1182/blood.V120.21.1768.1768

Published: 2012

Journal Articles

Recurrent ATM and BIRC3 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) and Deletion 11q22-q23

Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Sandra Weissmann, PhD, Sabine Jeromin, PhD, Jennifer Kienast, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 1771.

https://doi.org/10.1182/blood.V120.21.1771.1771

Published: 2012

Journal Articles

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Vera Grossmann, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Ulrike Bacher, MD, Franziska Poetzinger, Sandra Weissmann, PhD, Andreas Roller, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Melanie Zenger, Marita Staller, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 1394.

https://doi.org/10.1182/blood.V120.21.1394.1394

Published: 2012

Journal Articles

Analysis of SF3B1 in a Large Cohort of Refractory Anemia with Ring Sideroblasts with/without Marked Thrombocytosis (RARS-T/RARS) in an European Multicentre Study Reveals a High Incidence (86.3%) of Mutations and an Independent Favorable Association with Outcome

Susanne Schnittger, PhD, Ulrich Germing, Julien Broseus, Vera Grossmann, MSc, Tamara Alpermann, Lourdes Florensa Brichs, MD, Eric Lippert, PhD, Francois Liferman, MD, Sabine Jeromin, PhD, Torsten Haferlach, MD, Francois Girodon, MD, PhD

Blood (2012) 120 (21): 3798.

https://doi.org/10.1182/blood.V120.21.3798.3798

Published: 2012

Journal Articles

The Impact of Homozygosity and Size of the 13q Deletion in Patients with CLL

Claudia Haferlach, MD, Melanie Zenger, Vera Grossmann, MSc, Frank Dicker, PhD, Sabine Jeromin, PhD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 3892.

https://doi.org/10.1182/blood.V120.21.3892.3892

Published: 2012

Journal Articles

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Sabine Jeromin, PhD, Ulrike Bacher, MD, Katharina Bayer, Frank Dicker, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 406.

https://doi.org/10.1182/blood.V120.21.406.406

Published: 2012

Journal Articles

Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPAL-TM) Has a High DNMT3A Mutation Frequency and Carries Further Genetic Features of Both AML and T-ALL: Results of a Comprehensive Next-Generation Sequencing Study Analyzing 32 Genes

Wolfgang Kern, MD, Vera Grossmann, MSc, Andreas Roller, PhD, Sandra Weissmann, PhD, Tamara Alpermann, Ulrike Schoeck, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2012) 120 (21): 403.

https://doi.org/10.1182/blood.V120.21.403.403

Published: 2012

Journal Articles

Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse

Susanne Schnittger, PhD, Tamara Alpermann, Niroshan Nadarajah, MSc, Vera Grossmann, MSc, Christiane Eder, PhD, Alexander Kohlmann, PhD, Annette Fasan, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 408.

https://doi.org/10.1182/blood.V120.21.408.408

Published: 2012

Journal Articles

RUNX1 Deletions Are a Novel Mechanism of Loss of Function in AML and Are Associated with Adverse Cytogenetics.

Claudia Haferlach, MD, Vera Grossmann, MSc, Melanie Zenger, Wolfgang Kern, MD, Torsten Haferlach, MD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 2517.

https://doi.org/10.1182/blood.V120.21.2517.2517

Published: 2012

Journal Articles

Prognostic Impact of NOTCH1 Mutations in Chronic Lymphocytic Leukemia (CLL): A Study On 538 Patients.

Sandra Weissmann, PhD, Andreas Roller, PhD, Vera Grossmann, MSc, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Alexander Kohlmann, PhD

Blood (2012) 120 (21): 2873.

https://doi.org/10.1182/blood.V120.21.2873.2873

Published: 2012

Journal Articles

First Results of a 31-Gene Panel Targeted to Investigate Myeloid Malignancies by Next-Generation Amplicon Deep-Sequencing

Alexander Kohlmann, PhD, Sandra Weissmann, PhD, Ulrike Schoeck, MSc, Vera Grossmann, MSc, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 883.

https://doi.org/10.1182/blood.V120.21.883.883

Published: 2012

Journal Articles

The Landscape of RUNX1 Mutations in Acute Myeloid Leukemia: Investigations On Stability of Mutations At Relapse and Utility As a Marker for Minimal Residual Disease

Alexander Kohlmann, PhD, Niroshan Nadarajah, MSc, Vera Grossmann, MSc, Tamara Alpermann, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 657.

https://doi.org/10.1182/blood.V120.21.657.657

Published: 2012

Journal Articles

The Type of Genetic Abnormalities Causing Loss of 5q Varies Between MDS and AML and Is Associated with Worse Prognosis in MDS

Claudia Haferlach, MD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 697.

https://doi.org/10.1182/blood.V120.21.697.697

Published: 2012

Journal Articles

SF3B1 Mutations Have Adverse Impact On Time to Treatment Especially in Patients with 13q Deletions: A Study On 1,124 Chronic Lymphocytic Leukemia (CLL) Patients

Sabine Jeromin, PhD, Claudia Haferlach, MD, Katharina Bayer, Frank Dicker, PhD, Sandra Weissmann, PhD, Vera Grossmann, MSc, Tamara Alpermann, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 709.

https://doi.org/10.1182/blood.V120.21.709.709

Published: 2012

Journal Articles

High Incidence of RAS Signalling Pathway Mutations in MLL –rearranged Acute Myeloid Leukemia

Vera Grossmann, MSc, Susanne Schnittger, PhD, Alexander Kohlmann, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 539.

https://doi.org/10.1182/blood.V120.21.539.539

Published: 2012

NARROW

Two Novel Distinct Subtypes of Myeloid Neoplasms Molecularly Associated with Histone H3K36 Methylations

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Mutational Complexity Is Related To Disease Severity In Systemic Mastocytosis

Analysis of 12 Genes in 268 Cases with CMML Identifies ASXL1 Mutations As the Most Important Genetic Alteration Associated with Adverse Outcome

Acute Lymphoblastic Leukemia (ALL) with Low-Hypodiploid/near Triploid Karyotype Is a Specific Clinical Entity with Poor Outcome

Acquisition of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients During the Course of Disease Is Associated with an Unmutated IGHV Status and Mutations in XPO1 and SF3B1

Recurrent ATM and BIRC3 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) and Deletion 11q22-q23

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Analysis of SF3B1 in a Large Cohort of Refractory Anemia with Ring Sideroblasts with/without Marked Thrombocytosis (RARS-T/RARS) in an European Multicentre Study Reveals a High Incidence (86.3%) of Mutations and an Independent Favorable Association with Outcome

The Impact of Homozygosity and Size of the 13q Deletion in Patients with CLL

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPAL-TM) Has a High DNMT3A Mutation Frequency and Carries Further Genetic Features of Both AML and T-ALL: Results of a Comprehensive Next-Generation Sequencing Study Analyzing 32 Genes

Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse

RUNX1 Deletions Are a Novel Mechanism of Loss of Function in AML and Are Associated with Adverse Cytogenetics.

Prognostic Impact of NOTCH1 Mutations in Chronic Lymphocytic Leukemia (CLL): A Study On 538 Patients.

First Results of a 31-Gene Panel Targeted to Investigate Myeloid Malignancies by Next-Generation Amplicon Deep-Sequencing

The Landscape of RUNX1 Mutations in Acute Myeloid Leukemia: Investigations On Stability of Mutations At Relapse and Utility As a Marker for Minimal Residual Disease

The Type of Genetic Abnormalities Causing Loss of 5q Varies Between MDS and AML and Is Associated with Worse Prognosis in MDS

SF3B1 Mutations Have Adverse Impact On Time to Treatment Especially in Patients with 13q Deletions: A Study On 1,124 Chronic Lymphocytic Leukemia (CLL) Patients

High Incidence of RAS Signalling Pathway Mutations in MLL –rearranged Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only